Genibet Biopharmaceuticals

GenIbet Biopharmaceuticals is a GMP biopharmaceutical CDMO offering specialized manufacturing and development services to research groups, biotech and pharma companies, focused on manufacturing and supplying materials for early-stage drug development, pre-clinical studies and GMP clinical trial manufacturing, complemented by in-house fill and finish capabilities that let clients go from bench to clinic in a single facility. GenIbet's shareholders include Instituto de Biologia Experimental e Tecnológica (iBET) and leading Portuguese pharma and food companies, with the company achieving certification in the bacterial market in June 2009.